The peritumoral brain zone in glioblastoma: where we are and where we are going
Open Access
- 27 October 2022
- journal article
- review article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 101 (2) , 199-216
Abstract
Glioblastoma (GBM) is the most aggressive and invasive primary brain tumor. Current therapies are not curative, and patients' outcomes remain poor with an overall survival of 20.9 months after surgery. The typical growing pattern of GBM develops by infiltrating the surrounding apparent normal brain tissue within which the recurrence is expected to appear in the majority of cases. Thus, in the last decades, an increased interest has developed to investigate the cellular and molecular interactions between GBM and the peritumoral brain zone (PBZ) bordering the tumor tissue. The aim of this review is to provide up‐to‐date knowledge about the oncogenic properties of the PBZ to highlight possible druggable targets for more effective treatment of GBM by limiting the formation of recurrence, which is almost inevitable in the majority of patients. Starting from the description of the cellular components, passing through the illustration of the molecular profiles, we finally focused on more clinical aspects, represented by imaging and radiological details. The complete picture that emerges from this review could provide new input for future investigations aimed at identifying new effective strategies to eradicate this still incurable tumor.Keywords
This publication has 166 references indexed in Scilit:
- Cerebral Blood Volume Calculated by Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging: Preliminary Correlation Study with Glioblastoma Genetic ProfilesPLOS ONE, 2013
- Gene Expression Profile of Glioblastoma Peritumoral Tissue: An Ex Vivo StudyPLOS ONE, 2013
- Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survivalNeuro-Oncology, 2012
- Vascular Endothelial Growth Factor Receptor 2 as a Marker for Malignant Vascular Tumors and MesotheliomaAmerican Journal of Surgical Pathology, 2012
- Inhibition of T‐type Ca2+channels by endostatin attenuates human glioblastoma cell proliferation and migrationBritish Journal of Pharmacology, 2012
- The Three-Layer Concentric Model of Glioblastoma: Cancer Stem Cells, Microenvironmental Regulation, and Therapeutic ImplicationsThe Scientific World Journal, 2011
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- Classification of brain tumor type and grade using MRI texture and shape in a machine learning schemeMagnetic Resonance in Medicine, 2009
- Most mammalian mRNAs are conserved targets of microRNAsGenome Research, 2008
- Diffuse glioma growth: a guerilla warActa Neuropathologica, 2007